APFM Section 2 Module 3: Value Assessment
Module Description
Target Audience
Pharmacists, Pharmacy Technicians, Managed Care Professionals
Learning Objectives
At the completion of this activity, participants should be able to:
- Discuss the role of value assessment in formulary development and management.
- Define the key components of a value assessment and how best to assess use in formulary decision-making.
- Compare and contrast the types of value assessments.
- Identify resources used for value assessments and their strengths and weaknesses.
Faculty:
Tori Dayer, PharmD
Graduate Student
University of Washington
Sean Sullivan, PhD
Professor and Dean
The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute
University of Washington
Financial Relationship Disclosures:
Faculty/Reviewer/Planner | Reported Relevant Financial Relationships |
Tori Dayer, PharmD Faculty | Research Associate, Curta Health, Consultant, Novartis Gene Therapies |
Sean Sullivan, PhD Faculty | None |
- AMCP Staff have disclosed no relevant financial relationships.
- If applicable, relevant financial relationships have been mitigated and documented.
- Content has undergone a peer review to ensure content validity.
Accreditation:
ACPE UAN:0233-0000-23-026-H04-P • Activity Type: Knowledge-Based
Contact Hours: 0.75
Release Date: August 04, 2023 • Expiration Date: July 31, 2026
CPE credit will be processed through the AMCP Learn portal and reported directly to CPE Monitor. Please allow 72 hours for processing and posting in your NABP account.
To receive credit for an online activity you must:
- Review the full content of the activity.
- Successfully complete the post-test (required to pass with a score of 70% or higher, it may be taken a maximum of three times).
- Complete a specific activity evaluation.